Researchers are developing a new method for treating blood cancer. Virus-derived particles have been developed that destroy blood cancer cells, while leaving normal cells unharmed. Ottawa researchers altered viruses so that the particles could no longer replicate. The viruses however, maintained the ability to kill human leukemia cells in lab tests.
According to researcher Dr. David Conrad, "We were delighted to see that this novel therapy was very safe at high doses, and worked extremely well in our laboratory leukemia models. We hope to test this in patients in the near future." The researchers state that this type of therapy is promising due to its long-lasting effect on leukemia, along with its relatively minor side effects.
Learn more about this study:
- Virus-Derived Particles Target Blood Cancer (Science Daily)